Company news
ImmuPharma plc news in 2017
ImmuPharma plc's news releases, calls and decks from 2017, newest first.
Last patient completes dosing in LupuzorT Trial
December 21, 2017
Update on LupuzorT Pivotal Phase III Study
November 2, 2017
Completion of Lanstead Sharing Agreement
October 4, 2017
Preparation of Lupuzor'sT Regulatory Submissions
September 26, 2017
Notification of Interim Results
September 19, 2017
AIM Rule 17 Notice
August 18, 2017
Annual Report & Notice of AGM
June 7, 2017
Notification of Full Year Results
May 22, 2017
Update on Lupuzor Phase III Study
May 17, 2017
New Employee Share Option Plan & Grant of Options
March 31, 2017
ImmuPharma to present at Master Investor Show
March 24, 2017
£4.1 Million Fund Raise via Accelerated Bookbuild
March 10, 2017
Change of Adviser
January 24, 2017